Moderna expects to report vaccine data for young children in March
Premium
1 min read . Updated: 13 Jan 2022, 07:12 PM IST If the data are supportive and, subject to regulatory consultation, Moderna may proceed with regulatory filings
Premium 1 min read . Updated: 13 Jan 2022, 07:12 PM IST Moderna Inc. on Wednesday said it expects to report data from its Covid-19 vaccine trial in children ages 2 to 5 in March.
